Immucell Stock Technical Analysis
| ICCC Stock | USD 6.46 0.06 0.94% |
As of the 5th of March, ImmuCell retains the Risk Adjusted Performance of 0.1322, market risk adjusted performance of 0.4692, and Downside Deviation of 2.57. ImmuCell technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
ImmuCell Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ImmuCell, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ImmuCellImmuCell's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.ImmuCell Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 14.0 | Strong Buy | 1 | Odds |
Most ImmuCell analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ImmuCell stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ImmuCell, talking to its executives and customers, or listening to ImmuCell conference calls.
Will Biotechnology sector continue expanding? Could ImmuCell diversify its offerings? Factors like these will boost the valuation of ImmuCell. Market participants price ImmuCell higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ImmuCell data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.63) | Earnings Share 0.21 | Revenue Per Share | Quarterly Revenue Growth 0.178 | Return On Assets |
Understanding ImmuCell requires distinguishing between market price and book value, where the latter reflects ImmuCell's accounting equity. The concept of intrinsic value - what ImmuCell's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push ImmuCell's price substantially above or below its fundamental value.
Please note, there is a significant difference between ImmuCell's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmuCell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, ImmuCell's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
ImmuCell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ImmuCell's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ImmuCell.
| 12/05/2025 |
| 03/05/2026 |
If you would invest 0.00 in ImmuCell on December 5, 2025 and sell it all today you would earn a total of 0.00 from holding ImmuCell or generate 0.0% return on investment in ImmuCell over 90 days. ImmuCell is related to or competes with Aprea Therapeutics, Adial Pharmaceuticals, Kiora Pharmaceuticals, Cardio Diagnostics, and Phio Pharmaceuticals. ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and... More
ImmuCell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ImmuCell's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ImmuCell upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.57 | |||
| Information Ratio | 0.151 | |||
| Maximum Drawdown | 13.71 | |||
| Value At Risk | (4.42) | |||
| Potential Upside | 5.49 |
ImmuCell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ImmuCell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ImmuCell's standard deviation. In reality, there are many statistical measures that can use ImmuCell historical prices to predict the future ImmuCell's volatility.| Risk Adjusted Performance | 0.1322 | |||
| Jensen Alpha | 0.4484 | |||
| Total Risk Alpha | 0.349 | |||
| Sortino Ratio | 0.1752 | |||
| Treynor Ratio | 0.4592 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ImmuCell's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ImmuCell March 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1322 | |||
| Market Risk Adjusted Performance | 0.4692 | |||
| Mean Deviation | 2.32 | |||
| Semi Deviation | 2.27 | |||
| Downside Deviation | 2.57 | |||
| Coefficient Of Variation | 602.94 | |||
| Standard Deviation | 2.98 | |||
| Variance | 8.89 | |||
| Information Ratio | 0.151 | |||
| Jensen Alpha | 0.4484 | |||
| Total Risk Alpha | 0.349 | |||
| Sortino Ratio | 0.1752 | |||
| Treynor Ratio | 0.4592 | |||
| Maximum Drawdown | 13.71 | |||
| Value At Risk | (4.42) | |||
| Potential Upside | 5.49 | |||
| Downside Variance | 6.6 | |||
| Semi Variance | 5.16 | |||
| Expected Short fall | (2.72) | |||
| Skewness | 0.2489 | |||
| Kurtosis | (0.14) |
ImmuCell Backtested Returns
ImmuCell appears to be somewhat reliable, given 3 months investment horizon. ImmuCell holds Efficiency (Sharpe) Ratio of 0.0948, which attests that the entity had a 0.0948 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for ImmuCell, which you can use to evaluate the volatility of the firm. Please utilize ImmuCell's Risk Adjusted Performance of 0.1322, market risk adjusted performance of 0.4692, and Downside Deviation of 2.57 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, ImmuCell holds a performance score of 7. The company retains a Market Volatility (i.e., Beta) of 1.06, which attests to a somewhat significant risk relative to the market. ImmuCell returns are very sensitive to returns on the market. As the market goes up or down, ImmuCell is expected to follow. Please check ImmuCell's maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside , to make a quick decision on whether ImmuCell's current trending patterns will revert.
Auto-correlation | 0.17 |
Very weak predictability
ImmuCell has very weak predictability. Overlapping area represents the amount of predictability between ImmuCell time series from 5th of December 2025 to 19th of January 2026 and 19th of January 2026 to 5th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ImmuCell price movement. The serial correlation of 0.17 indicates that over 17.0% of current ImmuCell price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | 0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
ImmuCell technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
ImmuCell Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for ImmuCell across different markets.
About ImmuCell Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ImmuCell on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ImmuCell based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ImmuCell price pattern first instead of the macroeconomic environment surrounding ImmuCell. By analyzing ImmuCell's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ImmuCell's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ImmuCell specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 45.65 | 52.51 | 47.26 | 32.42 | PTB Ratio | 1.57 | 1.53 | 1.76 | 1.8 |
ImmuCell March 5, 2026 Technical Indicators
Most technical analysis of ImmuCell help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ImmuCell from various momentum indicators to cycle indicators. When you analyze ImmuCell charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1322 | |||
| Market Risk Adjusted Performance | 0.4692 | |||
| Mean Deviation | 2.32 | |||
| Semi Deviation | 2.27 | |||
| Downside Deviation | 2.57 | |||
| Coefficient Of Variation | 602.94 | |||
| Standard Deviation | 2.98 | |||
| Variance | 8.89 | |||
| Information Ratio | 0.151 | |||
| Jensen Alpha | 0.4484 | |||
| Total Risk Alpha | 0.349 | |||
| Sortino Ratio | 0.1752 | |||
| Treynor Ratio | 0.4592 | |||
| Maximum Drawdown | 13.71 | |||
| Value At Risk | (4.42) | |||
| Potential Upside | 5.49 | |||
| Downside Variance | 6.6 | |||
| Semi Variance | 5.16 | |||
| Expected Short fall | (2.72) | |||
| Skewness | 0.2489 | |||
| Kurtosis | (0.14) |
ImmuCell March 5, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as ImmuCell stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 484.14 | ||
| Daily Balance Of Power | 0.23 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 6.33 | ||
| Day Typical Price | 6.37 | ||
| Price Action Indicator | 0.16 |
Complementary Tools for ImmuCell Stock analysis
When running ImmuCell's price analysis, check to measure ImmuCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuCell is operating at the current time. Most of ImmuCell's value examination focuses on studying past and present price action to predict the probability of ImmuCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuCell's price. Additionally, you may evaluate how the addition of ImmuCell to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |